A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade

Ngoi, NYL; Peng, G; Yap, TA

Yap, TA (通讯作者),Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Phase I Clin Trials Program, Houston, TX 77030 USA.;Yap, TA (通讯作者),Univ Texas MD Anderson Canc Ctr, Khalifa Inst Personalized Canc Therapy, Houston, TX 77030 USA.;Yap, TA (通讯作者),Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.;Yap, TA (通讯作者),Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA.

ANNUAL REVIEW OF MEDICINE, 2022; 73 (): 231

Abstract

Innate immunity and the DNA damage response (DDR) pathway are inextricably linked. Within the DDR, ataxia telangiectasia and Rad3-related (ATR) is a k......

Full Text Link